Authors:
Berry, CN
Lorrain, J
Lochot, S
Delahaye, M
Lale, A
Savi, P
Lechaire, I
Ferrari, P
Bernat, A
Schaeffer, P
Janiak, P
Duval, N
Grosset, A
Herbert, JM
O'Connor, SE
Citation: Cn. Berry et al., Antiplatelet and antithrombotic activity of SL65.0472, a mixed 5-HT1B/5-HT2A receptor antagonist, THROMB HAEM, 85(3), 2001, pp. 521-528
Authors:
Savi, P
Bernat, A
Lale, A
Roque, C
Zamboni, G
Herbert, JM
Citation: P. Savi et al., Effect of aspirin on platelet desaggregation induced by SR121566, a potentGP-IIb/lIIa antagonist, PLATELETS, 11(1), 2000, pp. 43-48
Authors:
Herault, JP
Perrin, B
Jongbloet, C
Pflieger, AM
Bernat, A
Herbert, JM
Citation: Jp. Herault et al., Effect of factor Xa inhibitors on the platelet-derived microparticles procoagulant activity in vitro and in vivo in rats, THROMB HAEM, 84(4), 2000, pp. 668-674
Authors:
Hoffmann, P
Sainte Marie, M
Bernat, A
Rogue, C
Fedeli, O
Volk, A
Meric, P
Herbert, JM
Citation: P. Hoffmann et al., Stroke outcome determination with a prefabricated fibrin-rich macroclot ina thromboembolic rat middle cerebral artery occlusion model, FIBRINOL PR, 13(4-5), 1999, pp. 193-201
Authors:
Herbert, JM
Bernat, A
Chatenet-Duchene, L
Citation: Jm. Herbert et al., Effect of ciprofibrate on fibrinogen synthesis in vitro on hepatoma cells and in vivo in genetically obese Zucker rats, BL COAG FIB, 10(5), 1999, pp. 239-244
Authors:
Bernat, A
Hoffmann, P
Savi, P
Lale, A
Herbert, JM
Citation: A. Bernat et al., Interspecies comparison of the antiplatelet, antithrombotic, and hemorrhagic effects of SR 121566A, a novel nonpeptide GP IIb IIIa antagonist, J CARDIO PH, 33(6), 1999, pp. 897-904
Authors:
Bernat, A
Savi, P
Lale, A
Hoffmann, P
Herbert, JM
Citation: A. Bernat et al., The antithrombotic efficacy of the GP IIb/IIIa antagonist SR121787 is potentiated by antithrombin-dependent factor Xa inhibition without an increase in the bleeding risk in the rabbit, J CARDIO PH, 33(4), 1999, pp. 573-579